MAXONA Pharmaceuticals has submitted an investigational new drug (IND) application seeking approval from the US Food and Drug Administration (FDA) for its lead compound, MAX-001, to treat acute pain.

A groundbreaking wireless implant promises real-time, personalized pain relief using AI and ultrasound power no batteries, no wires, and no opioids. Designed by USC and UCLA engineers, it reads brain ...

A team of engineers from the University of Southern California (USC) and University of California, Los Angeles (UCLA) has built a wireless spinal implant that delivers real-time, personalised relief ...